Myocardial revascularization and ventricular restoration through pacopexy by Breda, Joao Roberto et al.
Original Article
Myocardial Revascularization and Ventricular Restoration through 
Pacopexy 
João Roberto Breda, Luciano Figueiredo Aguiar, João Nelson Rodrigues Branco, Roberto Catani, Ibraim Pinto, Edson 
Nakano, Enio Buffolo
Escola Paulista de Medicina – UNIFESP - São Paulo, SP - Brazil
Mailing Address: João Roberto Breda • 
Rua Ricardo Cavatton, 287/14 
Lapa de Baixo - 05038-110 – São Paulo, SP - Brazil 
E-mail: jbreda@cardiol.br
Manuscript received December 28, 2005; revised manuscript received 
May 15, 2006; accepted May 18, 2006.
Summary
Objective: To analyze left ventricle performance after myocardial revascularization associated to ventricular geometrics 
restoration by “pacopexy” in schemic myocardiopathy patients with significant ventricular dysfunction in whom 
ventricular restoration was obtained through special technique.
Methods: Myocardial revascularization associated to ventricular geometrics restoration through special technique, with 
no use of prosthesis or other synthetic materials.
Results: Patients’ functional class was shown to have improved 93.10% after surgical procedure. Pre- and post-surgical 
comparison showed significant increase in left ventricle ejection fraction as well as decrease in left ventricle systolic 
diameter. No significant change was observed in left ventricle diastolic diameter or systolic volume.  Post-surgical 
follow-up time length ranged from 1 month to 3 years and 4 months.
Conclusion: Ventricular dysfunction restoration technique through pacopexy showed to be effective for the management 
of severe ventricular dysfunction from schemic causes. Major impact was observed in the functional class of patients 
under study.
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Introduction
Cardiovascular diseases are responsible for the largest 
number of deaths in the Western World1. Among them 
Congestive Heart Failure (CHF) is accountable for quite a 
considerable share of deaths.
Approximately 23 million people are CHF carriers, and 2 
million new cases are diagnosed every year worldwide2. Major 
risk factor for the development of CHF in the US is ischemic 
heart disease3.
In Brazil, data from the Ministry of Health (Unified 
Health System – DATASUS) show that about one third of 
patients admitted to hospitals are diagnosed with CHF4.
Although epidemiological data are not accurate, ischemic 
heart diseases can be estimated to also be accountable as 
a major etiologic factor in our scenario.  Chagas disease, in 
its turn, and rheumatic fever are still posed as challenges to 
be overcome5,6.
From all surgical options for ischemic myocardiopathy 
treatment, isolated myocardial revascularization stands out7,8.
However, the development of refractory CHF in coronary 
artery disease carriers is associated to ventricular dilation and 
changes in ventricular sphericity, with the development of 
mitral regurgitation8-14.
The concept of the helicoid heart as described by Torrent-
Guasp – spiral, double helix left ventricular dynamics 
- emphasizes the relevance of cardiac structure for better 
hemodynamic performance. The loss of heart elyptical 
shape results in significant changes in the ventricular 
ability of getting filled with and/or ejecting blood.  Surgical 
procedures carried out with the purpose to restore the 
cardiac architecture responsible for normal function are 
called “pacopexy”, after Francisco Torrent-Guasp, who 
contributed with the bases for the surgical techniques 
designed to improve ventricular performance15.
Although “pacopexy” procedures are more favorable 
in dilated myocardiopathies with secondary mitral failure, 
its utilization has been expanded for the exclusion of left 
ventricle fibrotic regions, especially for the treatment of the 
interventricular septum12,15.
The purpose of this paper is to analyze left ventricle 
performance following myocardial revascularization, as well 
as ventricular geometrics restorarion through “pacopexy” 
in patients who are ischemic myocardiopathy carriers 
and who present significant ventricular dysfunction, and 
whose ventricular restoration was obtained through special 
technique. Left ventricle performance was analyzed through 
clinical and echocardiographic data, with left ventricle 
ejection fraction (LVEF), cavitary diameters, and systolic 
volume having been assessed.
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Methods
Thirty-four ischemic myocardiopathy patients were 
submitted to myocardial revascularization associated to 
“pacopexy” in the time period between February, 2000 and 
November, 2004.  The group was made up by 27 males and 
07 females, age range 43-73 years of age (mean 60.50 +
8.86 years of age). 
All patients had ischemic myocardiopathy and clinical 
condition compatible with CHF – current or previous. 
At immediate preoperative, 3 patients (8.83%) reported 
functional class II (FC II); 22 (64.70%) patients reported FC 
III; and 9 patients (24.47%) reported FC IV, following New 
York Heart Association (NYHA) classification, with associated 
congestive symptoms despite proper medication dosing. 
Post-surgery follow-up varied from 1 month to 3 years and 4 
months (mean 9.67 + 7.23 months).
Patients presented the following characteristics:  systolic 
and diastolic dilation of left ventricular cavity measured by 
transthoracic echocardiogram; significant left ventricular 
contractility deficit, measured by transthoracic echocardiogram 
and/or left ventriculography during cinecoronariography. 
All patients were submitted to myocardial revascularization 
associated to ventricular geometric restoration through 
“pacopexy”. Two patients also had concurrent correction 
of mitral regurgitation though valvoplasty, when Carpentier-
Edwards annuloplasty ring was applied.
Study protocol was approved by the Research and Ethics 
Committee at Escola Paulista de Medicina (UNIFESP). Patients 
agreed to participate by signing the informed consent.
Surgery technique - Surgery started with hemodynamic 
monitoring through average blood pressure measuring, central 
venous pressure measuring, and urinary debit, in addition to 
respiratory monitoring with pulse oximetry.
Surgery was carried out as routine, with access through 
median esternotomy, with aortic and lower cava cannulation 
through right atrium (or bicaval when mitral valve approach 
was necessary) after systemic heparinization (4 mg/kg), under 
moderate hypothermia at 32 °C.
Hypothermic antegrade cardioplegy was used as myocardial 
protection method (approximately at 18 °C), with potassium 
increase (15 mEq/l) at induction. Perfusion blood at 32 °C was 
administered in subsequent doses at 15-minute intervals and 
with no other substance added. 
After anastomoses were carried out between revascularizable 
coronary arteries, and after graft was selected (left inner 
thoracic artery or saphena), “pacopexy” was carried out in 
the left ventricle.
Ventricular geometry restoration through “pacopexy” 
includes ventriculotomy parallel to anterior interventricular 
coronary artery followed by inspection of septal portion and 
of ventricle free wall, with the identification and delimitation 
of areas with fibrosis. The free ventricle wall was then sutured 
to septal portion with the purpose of excluding fibrosis areas 
in anterior wall and anterior third of septum. With free wall 
imbricated to septal portion, the procedure was finalized 
by suturing remaining septal portion over free wall through 
hemostatic continuous suture. 
A full, 28 mm Carpentier-Edwards annuloplasty ring was 
applied to the two patients who reported significant mitral 
reflux.
After surgery, normothermic patients were taken to 
Post-Surgery Unit, where they were kept under full time 
monitoring. 
Patients had the same surgery team member in charge of 
both in-hospital and outpatient unit follow-up. A protocol 
was filled out to be used for comparison between pre- and 
post-surgery data. 
Statistical analysis - Statistical analyses compared parameters 
studied at three observation points in time, where data were 
collected from each patient. Observations were carried out 
in the following time periods: 1) Before surgery – Pre-Surgical 
Observation; 2) Prior to Discharge – Post-Surgical Observation; 
3) After discharge – Current Observation.
Parameters observed were: Left Ventricle Ejection Fraction; 
Left Ventricle Diastolic Diameter; Left Ventricle Systolic 
Diameter; Systolic Volume.
With the purpose of verifying statistical relevance of 
parameters differences along time, non-parametric hypotheses 
tests were carried out by comparing the following pairs in 
the evolution of each parameter (pre-surgery x post-surgery; 
pre-surgery x current measure; post-surgery x current 
measure). Willcoxon (signed rank) is the appropriate test for 
the comparison of paired samples.
Results
Functional class - Patients’ anaysis in regard to functional 
class evolution prior to and after surgery showed that except for 
deaths, 93.10% of patients had functional class improvement, 
while only 6.9% (2 patients) did not report improvement 
(Graph 1).
Ventricular function – 
a) Left Ventricle Ejection Fraction (LVEF): No significant 
statistic difference was reported for immediate post-surgery 
LVEF when pre-surgery (36±11.91) and post-surgery data 
were compared (32±9.80) (p = 0.1349); neither for pre-
surgery and current level (40±10.26) (p = 0.1854). However, 
in immediate post-surgery, significant increase was reported 
when data were compared with currrent levels (p = 0.0002) 
(Graph 2);
b) Systolic volume: No statistic evidence was reported 
for systolic volume variation at pre-operative or immediate 
post-operative points in time, neither in current observations 
(Graph 3).
Values:
• Pre-operative (118±62) – Post-operative (139.76±52.79) 
(p = 0.2191)
• Pre-operative (118±62) - Current (111±47.86) (p = 
0.7854)
• Post-operative (139.76±52.79) – Current (111±47.86) 
(p = 0.2049)
c) Left ventricle diastolic diameter (LVDD): 
No statistic evidence was reported for diastolic diameter 
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variation at pre-operative or immediate post-operative points 
in time, neither in current observations (Graph 4).
Values:
• Pre-surgery (65.50±10.82) - Post-surgery (67±7.52) (p 
= 0.3380)
• Pre-surgery (65.50±10.82) - Current (64±7.26) (p = 
0.4689)
• Post-surgery (67±7.52) – Current (64±7.26) (p = 
0.0513)
c) Left ventricle systolic diameter (LVSD):
No significant variation was reported bewteen pre-
operative (53.85±10.83) or post-operative (55.95±7.76) (p 
= 0.1931) systolic diameter, neither between pre-operative 
and current (50±7.92) (p = 0.5721). 
Significant reduction was reported between immediate post-
operative levels and current levels (p = 0.0172) (Graph 5). 
Survival analysis - Data showed 5 deaths among the 34 
patients: 4 deaths were related to the object of study (2 from 
cardiogenic shock and 2 from ventricular arrhythmia), and 
1 unrelated. Surgery related deaths occurred within 8 days 
after procedure.  No other death was reported after that 
point in time.
Survival analysis by Kaplan-Meier curve resulted estimated 
survival average probability at 88.24%, CI5%, variation 
between 77.41% and 99.07% (Graph 6).
Discussion
The clinical treatment of CHF is based on the knowledge 
of hemodynamic and neurohumoral mechanisms of 
this syndrome.  However, the therapeutic mode is not 
definitive, and stands only for temporary life standard quality 
improvement16. Despite clinical treatment optimization, a 
considerable number of patients end up developing into more 
advanced stages of the disease, and heart transplant becomes 
elective treatment. 
The increase in number of patients that develop CHF is a 
result of longer survival periods following acute myocardial 
infarction (AMI), especially from more efficacious therapeutics 
for the management of coronary artery disease. However, that 
longer survival period is often associated to some degree of 
myocardial impairment caused by ventricular remodelling, 
which triggers a vicious cycle leading to heart failure17.
Post-infarction left ventricle remodelling is a complex 
phenomenon involving molecular, neurohormonal, and 
genetic factors. Those factors may result in cardiac chambers 
dilation, and ventricular change and dysfunction18.
Ischemic disease as the cause for CHF is a result of dilation 
and ventricular remodelling after myocardial infarction19.
Although early reperfusion of infarct-related artery - through 
thrombolysis or angioplasty – may limit ventricular dilation 
expansion, approximately 20% of patients may present such 
complication despite aggressive therapeutics20. In a recent 
study, Bolognese et al have observed that 30% of patients 
treated through successful primary angioplasty develop left 
ventricular dilation (defined as a 20% increase of final diastolic 
volume) within 6 months after the procedure21.
Myocardial revascularization in itself is a therapy option 
for those patients. The Coronary Artery Surgery Study (CASS) 
showed to be highly beneficial for the survival of revascularized 
patients with left ventricle ejection fraction (LVEF) below 
35%22. In addition to that study, the Veterans multicenter 
administration study (Veterans Administration Coronary Artery 
Bypass Surgery Cooperative Study Group) contributed with 
evidence of survival after myocardial revascularization of 
patients with serious ventricular dysfuncation and angina23.
Graphic 1 - Patients’ Evolution in regard to Functional Class:  pre and post-
surgery, mean follow-up period - 9.67 ±7.23 months.
Graphic 2 - Left Ventricle Ejection Fraction (LVEF) Distribution:  median and 
percentile.
1 - Pre-surgery 2- post-surgery 3- Current
36.00
32.00
40.00
p = 0.1854
p = 0.1349 p = 0.002
Graphic 3 - Distribution of Systolic Volume (SV) Values: median and 
percentile.
1 - Pre-surgery 2- post-surgery 3- Current
118.00
139.76
111.00
p = 0.07854
p = 0.2191 p = 0.2049
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Therefore, myocardial revascularization has the ability to 
increase LVEF, improve hemodynamic parameters, extend 
survival time, and reduce congestive symptoms. 
However, clinical or surgical treatment of the lesion 
blamed for myocardial ischemia is no guarantee for cure. 
Ventricular size and funcation must be assessed for prognostic 
determination in terms of heart failure development, which 
includes high economic and social impact17.
Therefore, the development of ischemic myocardiopathy 
is associated to ventricular dilation and possible mitral 
regurgitation, with changes in ventricular sphericity 
and resulting deterioration of systolic function. Surgical 
management of ischemic myocardiopathy should encompass 
coronary revascularization, correction of mitral regurgitation, 
and ventricular geometry restoration24.
Ventricular geometry restoration with ventricular volume 
reduction is based on the excision of obvious scar areas in 
left ventricle anterior wall. Excision and linear suture of those 
dyskinetic scar areas has been done for quite many years, 
although the technique may not properly treat fibrosis areas 
in the interventricular septum24. Endoventricular repair with 
septal imbrication is an attempt for a better approach for the 
treatment of interventricular septum; the surgical ventricular 
restoration strategy has been used both for dyskinetic and 
akinetic follow-ups of cardiac muscle14.
The principle of ventricular geometry restoration has been 
Graphic 4 - Left Ventricle Diastolic Diameter (LVDD) Values: median and 
percentile.
1 - Pre-surgery 2- post-surgery 3- Current
65.50
67.00
64.00
p = 0.4689
p = 0.3380 p = 0.0513
well described by Dor et al through endoventriculoplasty 
with a circular graft and the exclusion of all scar areas, 
with application both in discynesia and akinesia areas13. A 
multicenter study using that technique showed low mortality 
rate and acceptable survival after 3 years of follow-up, in 
addition to lower rate of repeat hospitalization due to CHF if 
compared to myocardial revascularization alone24. Another 
important contribution was brought up by the RESTORE 
group, made up of 10 international centers that have carried 
out ventricular restoration procedure since 199814.
Classical ventricular aneurysm is characterized by a 
diskynetic ventricular portion circumscribed by a collum that 
separates the scar area from contractile muscle. This sort of 
lesion can be corrected through Jatene’s technique, which 
recommends ventricular geometric reconstruction by using 
circumferencial suture in aneurysm collum, and the exclusion 
of discynesia area14. Currently, this type of lesion is not frequent 
as a result of the availability of early reperfusion techniques 
of the coronary artery under atherosclerosis. 
In the present study, ventricular geometry restoration 
was obtained through special technique “pacopexy”, which 
showed to be satisfactory, particularly for the treatment of 
scar areas in the interventricular septum. Additionally, the 
technique does not involve the use of synthetic material such 
as prostheses or tissue bars, and may, therefore contribute 
with lower tissue inflammatory response.  Previous studies 
have shown that bovine pericardium and teflon compounds 
are associated to mononuclear inflammatory infiltration in 
adjacent tissue and graft-host type immunological response 
induction25.
The follow-up of those patients showed significant 
functional improvement, with 93.10% of them showing 
improvement when pre and post-surgery Funcional Class (FC) 
was compared (Fig. 1), with possible benefits in terms of life 
standard quality.  
In regard to left ventricle ejection fraction, one could say it 
is not the best accuracy parameter in determining long-term 
results - ventricular volume analysis is crucial24.  In spite of that, 
some LVEF decrease could be observed between pre-surgery 
and immediate post-surgery (before hospital discharge), 
showing recovery when compared to current levels. 
After geometric restoration, left ventricular cavity size is a 
major factor in determining the survival of those patients.  In 
the present study, except for left ventricle systolic diameter 
(LVSD), all other ventricular volume parameters showed 
no statistically significant difference when comparing 
pre and post-surgery points in time.   The apparent lack 
of improvement in left ventricular preformance may be 
associated to the method used for assessment in the present 
study (transthoracic echocardiogram). That can be changed 
by using other methods (particularly MRI). 
Despite patients’ severe condition in the present study 
– due to pre-surgery ventricular dysfunction – post-surgery 
survival analysis showed to be favorable, with mean survival 
probability at 88.24%, in the period being considered. 
Survival curve was influenced by an 11% surgery mortality 
rate, basically related to the advanced stage of ventricular 
dysfunction presented by patients at the time of surgery. 
53.85
Graphic 5 - Left Ventricle Systolic Diameter (LVSD) Values Distribution: 
median and percentile.
55.95
50.00
p = 0.5721
p = 0.1931 p = 0.00172
1 - Pre-surgery 2- post-surgery 3- Current
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So, the ventricular restoration technique used in the 
present study differs from all other techniques described in 
the literature under research, especially for making available 
a wide option range for interventricular septum treatment, 
as well as for not making use of synthetic materials.  Classical 
linear suture does not properly correct the septal component; 
all other techniques involve circular sutures and many times 
the use of synthetic materials.
Successful ventricular restoration procedures are based 
on the following aspects: full myocardial revascularization, 
ventricular volume reduction, and shape restoration - all fully 
complied with in the technique used in the present study. 
Therefore, the understanding of normal heart anatomy and 
function will help the surgeon to use the techniques that will 
allow ventricular geometry to be restored as close as possible 
to ideal shape and size, with possible implication in ventricular 
Graphic 6 - Kaplan-Meier Curve.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 100 200 300 400 500 600 700 800 900
Função de Estimação de Distribuição de Sobrevivência
Limite Inferior de Confiança
Limite Superior de Confiança
Censuras
Dias
Pr
ob
ab
il
id
ad
e 
de
 S
ob
re
vi
vê
nc
ia
Gráfico de SobrevivênciaData on Survival 
Survival Distribution: Estimate Function
/RZHU&RQ¿GHQFH/HYHO
8SSHU&RQ¿GHQFH/HYHO
Censoring
Days
S
ur
vi
va
l P
ro
ba
bi
lit
y 
function improvement.
Conclusion
1. Statistically significant left ventricle ejection fraction 
increase was shown when comparing immediate post-surgery 
(before hospital discharge) and current evaluation data.
2. Significant reduction of left ventricle systolic diameter was 
shown when comparing post-surgery and current values.
3. Additional prospective studies are required for long term 
assessment of the results obtained in the present study.
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